Vimarsana
Biggest News Aggregation in the World

Page 35 - End Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from End Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In End Report Today - Breaking & Trending Today

Hövding Sverige AB: Hövding year-end report 2021 - Vimarsana News

Hövding Sverige AB: Hövding year-end report 2021

HÖVDING YEAR-END REPORT 2021October - December 2021 A year of transformation Financial results for the quarter Number of Hövding helmets sold 29,353 (33,854) (-13%)Net sales TSEK 50,284 (52

Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021 - Vimarsana News

Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021 - Vimarsana News

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum

Investegate |Immunicum AB Announcements | Immunicum AB: Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021 - Vimarsana News

Investegate |Immunicum AB Announcements | Immunicum AB: Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

Investegate announcements from Immunicum AB, Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021 - Vimarsana News

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum